6.916
price up icon0.61%   0.046
 
loading
Schlusskurs vom Vortag:
$6.87
Offen:
$6.77
24-Stunden-Volumen:
193.79K
Relative Volume:
0.64
Marktkapitalisierung:
$273.40M
Einnahmen:
$68.68M
Nettoeinkommen (Verlust:
$-60.84M
KGV:
-4.3225
EPS:
-1.6
Netto-Cashflow:
$-38.42M
1W Leistung:
+2.55%
1M Leistung:
-19.82%
6M Leistung:
-7.10%
1J Leistung:
-18.78%
1-Tages-Spanne:
Value
$6.665
$7.05
1-Wochen-Bereich:
Value
$6.40
$7.06
52-Wochen-Spanne:
Value
$5.46
$10.01

Pulmonx Corp Stock (LUNG) Company Profile

Name
Firmenname
Pulmonx Corp
Name
Telefon
650-364-0400
Name
Adresse
700 CHESAPEAKE DRIVE, REDWOOD CITY
Name
Mitarbeiter
291
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
LUNG's Discussions on Twitter

Vergleichen Sie LUNG mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
LUNG
Pulmonx Corp
6.92 273.40M 68.68M -60.84M -38.42M -1.60
Medical Devices icon
ABT
Abbott Laboratories
131.70 225.32B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
100.76 149.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
375.31 142.48B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
88.69 113.49B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
72.11 42.10B 5.72B 4.17B 259.90M 6.97

Pulmonx Corp Stock (LUNG) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-10 Eingeleitet D. Boral Capital Buy
2024-12-11 Herabstufung Citigroup Buy → Neutral
2024-06-04 Eingeleitet Lake Street Buy
2024-02-23 Herabstufung Wells Fargo Overweight → Equal Weight
2023-09-05 Eingeleitet Craig Hallum Buy
2023-02-27 Hochstufung Wells Fargo Equal Weight → Overweight
2023-01-03 Herabstufung BofA Securities Neutral → Underperform
2022-12-12 Hochstufung Citigroup Neutral → Buy
2022-07-11 Herabstufung Citigroup Buy → Neutral
2022-03-02 Fortgesetzt BofA Securities Neutral
2021-12-08 Hochstufung Piper Sandler Neutral → Overweight
2021-04-01 Eingeleitet Citigroup Buy
2021-03-25 Eingeleitet Piper Sandler Neutral
2021-03-10 Hochstufung BofA Securities Neutral → Buy
2021-01-04 Herabstufung BofA Securities Buy → Neutral
2020-10-26 Eingeleitet BofA Securities Buy
2020-10-26 Eingeleitet Canaccord Genuity Buy
2020-10-26 Eingeleitet Morgan Stanley Equal-Weight
2020-10-26 Eingeleitet Stifel Buy
2020-10-26 Eingeleitet Wells Fargo Equal Weight
Alle ansehen

Pulmonx Corp Aktie (LUNG) Neueste Nachrichten

pulisher
Mar 29, 2025

Charles Schwab Investment Management Inc. Boosts Holdings in Pulmonx Co. (NASDAQ:LUNG) - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

Pulmonx Co. (NASDAQ:LUNG) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Mar 28, 2025
pulisher
Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Buys 25,988 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Insider Sell Alert: French Glendon E. III Sells 20,000 Shares of Pulmonx Corp (LUNG) - GuruFocus

Mar 22, 2025
pulisher
Mar 22, 2025

Pulmonx corp director Glendon French sells $157,000 in stock By Investing.com - Investing.com Canada

Mar 22, 2025
pulisher
Mar 21, 2025

Pulmonx corp director Glendon French sells $157,000 in stock - Investing.com

Mar 21, 2025
pulisher
Mar 21, 2025

Canaccord maintains Buy rating on Pulmonx stock with $16 target By Investing.com - Investing.com Australia

Mar 21, 2025
pulisher
Mar 21, 2025

Canaccord maintains Buy rating on Pulmonx stock with $16 target - Investing.com

Mar 21, 2025
pulisher
Mar 10, 2025

Boral Capital sets Pulmonx stock Buy rating, $17 target - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

Boral Capital sets Pulmonx stock Buy rating, $17 target By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

This Pulmonx Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Mar 10, 2025
pulisher
Mar 10, 2025

Pulmonx initiated with a Buy at D. Boral Capital - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Rhumbline Advisers Buys 2,488 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Pulmonx (NASDAQ:LUNG) vs. Spectral Medical (OTCMKTS:EDTXF) Financial Review - The AM Reporter

Mar 09, 2025
pulisher
Mar 07, 2025

Reviewing Pulmonx (NASDAQ:LUNG) & Spectral Medical (OTCMKTS:EDTXF) - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Pulmonx corp’s chief commercial officer sells $41,191 in stock - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Pulmonx corp general counsel sells shares totaling $170,918 - Investing.com India

Mar 06, 2025
pulisher
Mar 05, 2025

Pulmonx CFO Mehul Joshi sells $102,414 in stock By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Pulmonx Corp CEO Steven Williamson sells $197,699 in stock - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Pulmonx CFO Mehul Joshi sells $102,414 in stock - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Pulmonx corp’s chief commercial officer sells $41,191 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 03, 2025

Can This Medical Device Expert Help EDAP Dominate the $8.5B Prostate Cancer Market? - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

Pulmonx Co. (NASDAQ:LUNG) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Pulmonx director French Glendon E. III sells shares worth $29,625 - MSN

Mar 01, 2025
pulisher
Feb 24, 2025

Pulmonx director French Glendon E. III sells $459,085 in shares By Investing.com - Investing.com Canada

Feb 24, 2025
pulisher
Feb 24, 2025

Pulmonx director French Glendon E. III sells $459,085 in shares - Investing.com India

Feb 24, 2025
pulisher
Feb 21, 2025

Pulmonx Corporation shares spike on record-breaking Q4 revenue - Mugglehead

Feb 21, 2025
pulisher
Feb 21, 2025

Stock summary: Pulmonx witnessed weekly surge of 20.43% after fourth-quarter earnings exceed expectations - Business Upturn

Feb 21, 2025
pulisher
Feb 20, 2025

Top 3 Health Care Stocks You May Want To Dump In February - Benzinga

Feb 20, 2025
pulisher
Feb 20, 2025

Pulmonx Corporation (NASDAQ:LUNG) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 20, 2025
pulisher
Feb 20, 2025

Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates - MSN

Feb 20, 2025
pulisher
Feb 20, 2025

Citi raises Pulmonx stock target following record revenue - Investing.com India

Feb 20, 2025
pulisher
Feb 20, 2025

Citi raises Pulmonx stock target following record revenue By Investing.com - Investing.com Nigeria

Feb 20, 2025
pulisher
Feb 20, 2025

Pulmonx Corp (LUNG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Financial ... - Yahoo Finance

Feb 20, 2025
pulisher
Feb 19, 2025

Pulmonx earnings beat by $0.12, revenue topped estimates - Investing.com

Feb 19, 2025
pulisher
Feb 19, 2025

Earnings call transcript: Pulmonx Q4 2024 earnings beat expectations, stock jumps - Investing.com India

Feb 19, 2025
pulisher
Feb 19, 2025

Can Pulmonx's 22% Revenue Surge and Treatment Center Expansion Transform Severe COPD Care? - StockTitan

Feb 19, 2025
pulisher
Feb 19, 2025

What To Expect From Pulmonx Corp (LUNG) Q4 2024 Earnings - Yahoo Finance

Feb 19, 2025
pulisher
Feb 17, 2025

Pulmonx (LUNG) Expected to Announce Quarterly Earnings on Wednesday - Armenian Reporter

Feb 17, 2025
pulisher
Feb 13, 2025

Exclusive: Pulmonx Reveals Future Roadmap at Major Healthcare Investor Summit - StockTitan

Feb 13, 2025
pulisher
Feb 13, 2025

Pulmonx Co. (NASDAQ:LUNG) Stake Lifted by SG Americas Securities LLC - Defense World

Feb 13, 2025
pulisher
Feb 12, 2025

Pulmonx (LUNG) Projected to Post Quarterly Earnings on Wednesday - Defense World

Feb 12, 2025
pulisher
Feb 09, 2025

Pulmonx Co. (NASDAQ:LUNG) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Feb 09, 2025
pulisher
Feb 06, 2025

Pulmonx Co. (NASDAQ:LUNG) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Feb 06, 2025
pulisher
Feb 05, 2025

Pulmonx Earnings Watch: Key Q4 Financial Results Coming February 19Mark Your Calendar - Stock Titan

Feb 05, 2025
pulisher
Feb 04, 2025

Morgan Stanley Reduces Stake in Pulmonx Corp by 21.74% - GuruFocus.com

Feb 04, 2025
pulisher
Jan 29, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Jan 29, 2025

Finanzdaten der Pulmonx Corp-Aktie (LUNG)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices STE
$227.62
price up icon 0.80%
medical_devices ZBH
$112.47
price up icon 0.09%
medical_devices PHG
$24.92
price down icon 1.17%
$67.12
price down icon 0.77%
$79.03
price down icon 0.72%
medical_devices EW
$72.21
price up icon 0.49%
Kapitalisierung:     |  Volumen (24h):